Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Pre-filled syringe (Solution for injection or infusion) 2 X 5 ml |
|
Related information
Dosage
Please refer to the license holder for further details
Indications
Treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women not previously treated with hormonal therapy, or with disease relapse/progression on or after adjuvant endocrine therapy.
In combination with the preparation Palbociclib or Abemaciclib, is intended for women with advanced or metastatic estrogen receptor-positive and HER2-negative breast cancer, whose disease has progressed after receiving prior hormonal treatment for this ailment.
In combination with Ribociclib, is intended for men and postmenopausal women with advanced or metastatic estrogen receptor-positive and HER2-negative breast cancer, whose disease has progressed after receiving prior endocrine treatment for this ailment or as initial endocrine treatment.
Contra-Indications
Please refer to the license holder for further details
Special Precautions
Please refer to the license holder for further details
Side Effects
Please refer to the license holder for further details
Drug interactions
Please refer to the license holder for further details
Pregnancy and Lactation
Please refer to the license holder for further details
Overdose
Please refer to the license holder for further details
